In this feature, we will be investigating chimeric antigen receptor T-cell therapies, their benefits and potential side effects, and what the future may hold for the development of this type of immunotherapy treatment.
Browsing: Advanced therapies
In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.
Discover more about the development of CAR-T cell therapies, their bioanalytical challenges and specialized antibody reagents that can be ustilized to overcome these in this interview with Michael Schwenkert (Bio-Rad Laboratories; Germany).
As part of our mini-Spotlight on cell and gene therapies, we carried out a survey to gain an insight into the trends, challenges and developments associated with these fields – find out the results in this informative infographic.
Webinar available to view on demand. Arno Kromminga and Lydia Michaut will discuss the strategies and challenges of immunogenicity assessment for gene therapy compounds.
In this free on demand panel discussion, our experts provide insights into their own research with cellular and gene therapies including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.